Drug · DIN 02369087
AG-RISPERIDONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since June 23, 2026; first marketed September 6, 2018.
- Drug Identification Number (DIN)
- 02369087
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 23, 2026: NOC 37754Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- August 22, 2011: NOC 12576Abbreviated New Drug Submission (ANDS) · New Manufacturer and Product Name
Other DINs named AG-RISPERIDONE
- DIN 02369079 · Dormant
- DIN 02369095 · Dormant
- DIN 02369117 · Dormant
- DIN 02369125 · Dormant
- DIN 02369133 · Dormant